Why I think these 5 FTSE 100 stocks are the best UK shares to buy now

These five FTSE 100 (INDEXFTSE:UKX) stocks are the best UK shares to buy now because they offer long-term growth potential, in my view.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Identifying the best UK shares to buy now from across the FTSE 100 is very subjective. However, I think they’re likely to be those companies that offer long-term growth potential because of industry trends, or because of their market positions.

Such companies may also offer less risk than their index peers. For example, they may enjoy wider economic moats, or have stronger financial positions as a result of past outperformance.

With that in mind, here are five FTSE 100 shares that could be worth buying today. Over the long run, they could produce market-beating returns that boost an investor’s portfolio performance.

Why pharmaceutical stocks could be among the best UK shares to buy now

FTSE 100 pharmaceutical companies such as AstraZeneca and GSK could be among the best UK shares to buy now. Both companies have solid market positions and could benefit from long-term industry growth trends. And that should lead to rising profitability and higher share prices over the coming years.

For example, the world’s population is growing in size and is also ageing. This may mean that demand for a variety of drugs increases over the coming years. With both companies having strong development pipelines, they may be able to capitalise on rising demand over a long timescale.

Clearly, AstraZeneca’s Covid-19 vaccine news has dominated headlines of late. This means it trades on a higher valuation than GSK. However, with the two companies having long-term growth opportunities, they may both merit higher valuations in the coming years that catalyses their share prices. As such, they may be among the best UK shares to buy now.

FTSE 100 consumer goods companies could outperform their index peers

FTSE 100 consumer goods companies such as Unilever, Diageo and Reckitt Benckiser may also be some of the best UK shares to buy now. Their market positions mean they could deliver improving financial performances as the prospects for the world economy improves.

Certainly, Diageo and Unilever have experienced tough operating conditions this year. Some of their key markets, such as hospitality venues, have led to disappointing sales that could persist in the short run. Meanwhile, Reckitt Benckiser’s sales growth could slow as demand for hygiene products eases off.

However, their exposure to some of the world’s fastest-growing economies could make them among the best UK shares to buy now. Within those markets, they have dominant positions as a result of their range of consumer goods that provide a wide economic moat as a result of their strong consumer loyalty.

Therefore, while their valuations may be relatively high compared to some FTSE 100 stocks, their capacity to deliver earnings growth appears to be high. This may result in improving share price performances as a stock market recovery and improving economic conditions take hold.

Peter Stephens owns shares of AstraZeneca, Diageo, GlaxoSmithKline, Reckitt Benckiser, and Unilever. The Motley Fool UK has recommended Diageo, GlaxoSmithKline, and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »